Your browser doesn't support javascript.
loading
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Munir, Talha; Brown, Jennifer R; O'Brien, Susan; Barrientos, Jacqueline C; Barr, Paul M; Reddy, Nishitha M; Coutre, Steven; Tam, Constantine S; Mulligan, Stephen P; Jaeger, Ulrich; Kipps, Thomas J; Moreno, Carol; Montillo, Marco; Burger, Jan A; Byrd, John C; Hillmen, Peter; Dai, Sandra; Szoke, Anita; Dean, James P; Woyach, Jennifer A.
Afiliación
  • Munir T; Department of Haematology, St. James's University Hospital, Leeds, UK.
  • Brown JR; CLL Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • O'Brien S; UC Irvine, Chao Family Comprehensive Cancer Center, Irvine, California.
  • Barrientos JC; Division of Medical Oncology and Hematology Northwell Health Cancer Institute, Lake Success, New York.
  • Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
  • Reddy NM; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
  • Coutre S; Stanford Cancer Center, Stanford University School of Medicine, Stanford, California.
  • Tam CS; Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, Australia.
  • Mulligan SP; Royal North Shore Hospital, Sydney, Australia.
  • Jaeger U; Division of Hematology and Hemostaseology, Medical University of Vienna, Wien, Austria.
  • Kipps TJ; UCSD Moores Cancer Center, San Diego, California.
  • Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
  • Montillo M; Niguarda Ca' Granda Hospital, Milan, Italy.
  • Burger JA; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Byrd JC; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Hillmen P; The Leeds Teaching Hospitals, St. James Institute of Oncology, Leeds, UK.
  • Dai S; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Szoke A; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Dean JP; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, California.
  • Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Am J Hematol ; 94(12): 1353-1363, 2019 12.
Article en En | MEDLINE | ID: mdl-31512258
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Terapia Recuperativa / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Terapia Recuperativa / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido